Crystal structure and substrate specificity of the β‐ketoacyl‐acyl carrier protein synthase III (FabH) from Staphylococcus aureus
暂无分享,去创建一个
[1] R. Heath,et al. The 1.8 A crystal structure and active-site architecture of beta-ketoacyl-acyl carrier protein synthase III (FabH) from escherichia coli. , 2000, Structure.
[2] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[3] C. Rock,et al. Overproduction of beta-ketoacyl-acyl carrier protein synthase I imparts thiolactomycin resistance to Escherichia coli K-12 , 1992, Journal of bacteriology.
[4] R J Heath,et al. Lipid biosynthesis as a target for antibacterial agents. , 2001, Progress in lipid research.
[5] J. Neel Scarsdale,et al. Crystal Structure of the Mycobacterium tuberculosisβ-Ketoacyl-Acyl Carrier Protein Synthase III* , 2001, The Journal of Biological Chemistry.
[6] F. Lowy. Staphylococcus aureus infections. , 2009, The New England journal of medicine.
[7] C. Rock,et al. Acetoacetyl-acyl carrier protein synthase, a potential regulator of fatty acid biosynthesis in bacteria. , 1987, The Journal of biological chemistry.
[8] P. Edwards,et al. Cloning of the fabF gene in an expression vector and in vitro characterization of recombinant fabF and fabB encoded enzymes from Escherichia coli , 1997, FEBS letters.
[9] M. Doyle,et al. Expression, Purification, and Crystallization of the Escherichia coli Selenomethionyl β-Ketoacyl–Acyl Carrier Protein Synthase III , 2000 .
[10] S. Levy,et al. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. , 1998, FEMS microbiology letters.
[11] R. Slayden,et al. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis , 2000, Molecular microbiology.
[12] Xiayang Qiu,et al. Crystal Structure of β-Ketoacyl-Acyl Carrier Protein Synthase III , 1999, The Journal of Biological Chemistry.
[13] S. Khandekar,et al. Bacterial beta-ketoacyl-acyl carrier protein synthases as targets for antibacterial agents. , 2003, Current protein & peptide science.
[14] David A. Mead,et al. Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP synthase by isoniazid , 1998 .
[15] C. Rock,et al. Acetoacetyl-acyl carrier protein synthase. A target for the antibiotic thiolactomycin. , 1989, The Journal of biological chemistry.
[16] K. Reynolds,et al. Characterization of β-Ketoacyl-Acyl Carrier Protein Synthase III from Streptomyces glaucescens and Its Role in Initiation of Fatty Acid Biosynthesis , 1998 .
[17] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[18] W. Jacobs,et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. , 1994, Science.
[19] T. Kaneda,et al. Iso- and anteiso-fatty acids in bacteria: biosynthesis, function, and taxonomic significance. , 1991, Microbiological reviews.
[20] K. Reynolds,et al. Crystal structure of a substrate complex of Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III (FabH) with lauroyl-coenzyme A. , 2005, Journal of molecular biology.
[21] M. Doyle,et al. Identification, Substrate Specificity, and Inhibition of theStreptococcus pneumoniae β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH)* , 2001, The Journal of Biological Chemistry.
[22] S. Abdel-Meguid,et al. Crystal structure of beta-ketoacyl-acyl carrier protein synthase III. A key condensing enzyme in bacterial fatty acid biosynthesis. , 1999, The Journal of biological chemistry.
[23] Charles O. Rock,et al. β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) Is a Determining Factor in Branched-Chain Fatty Acid Biosynthesis , 2000, Journal of bacteriology.
[24] T. Kaneda. Biosynthesis of branched chain fatty acids. II. Microbial synthesis of branched long chain fatty acids from certain short chain fatty acid substrates. , 1963, The Journal of biological chemistry.
[25] K. Reynolds,et al. Purification, Characterization, and Identification of Novel Inhibitors of the β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) from Staphylococcus aureus , 2002, Antimicrobial Agents and Chemotherapy.
[26] S. Abdel-Meguid,et al. Molecular basis for triclosan activity involves a flipping loop in the active site , 2008, Protein science : a publication of the Protein Society.
[27] C. Rock,et al. Isolation and characterization of the beta-ketoacyl-acyl carrier protein synthase III gene (fabH) from Escherichia coli K-12. , 1992, The Journal of biological chemistry.
[28] C. Rock,et al. Identification and substrate specificity of beta -ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis. , 2000, The Journal of biological chemistry.
[29] M. Head,et al. Refined structures of beta-ketoacyl-acyl carrier protein synthase III. , 2001, Journal of molecular biology.
[30] H. Oku. Biosynthesis of Branched-chain Fatty Acids. , 1996 .
[31] R. Heath,et al. Inhibition of β-Ketoacyl-Acyl Carrier Protein Synthases by Thiolactomycin and Cerulenin , 2001, The Journal of Biological Chemistry.